Isabella Palagiano to participate as speaker in the AEFI Safety in Clinical Trials Training

  • Post published:February 20, 2024

We are happy to announce that Isabella Palagiano will be participating as speaker in the AEFI Safety in Clinical trials Training. The training will take place on 29th February and 5th March and will be held online, please find more information about the training in the link below: https://aefi.org/eventos/seguridad-en-ensayos-clinicos/?mc_cid=b547e1ac35&mc_eid=54a2a50032 During the 29th, Isabella will be talking about several topics related to ICSRs transmission to Eudravigilance, MHAR and FDA. **PVpharm is also organizing in-house training in pharmacovigilance for pharmaceutical companies and CROs, please contact us for further information.**

Continue ReadingIsabella Palagiano to participate as speaker in the AEFI Safety in Clinical Trials Training

José Alberto Ayala Ortiz to participate as speaker in the AEFI Pharmacovigilance in Social Networks Training

  • Post published:November 2, 2023

We are happy to announce that José Alberto Ayala Ortiz, PVpharm's CEO will be participating as speaker in the AEFI Pharmacovigilance in Social Networks Training. The training will take place on Monday 6th November from 16:00 to 19:00, please find more information about the training in the link below: https://aefi.org/eventos/farmacovigilancia-en-la-era-digital/?mc_cid=ddb97c2046&mc_eid=54a2a50032 During the session, José will be talking about several topics related to Pharmacovigilance and handling of safety related information detected in Social Networks.

Continue ReadingJosé Alberto Ayala Ortiz to participate as speaker in the AEFI Pharmacovigilance in Social Networks Training

José Alberto Ayala Ortiz to participate in the AEFI Symposium 2023

  • Post published:June 1, 2023

We are happy to announce that José Alberto Ayala Ortiz, PVpharm's CEO will be participating in one session of the 2023 Pharmacovigilance symposium organized by AEFI. During the session, José will be talking about safety in food or food supplements. Please take a look to the program at this link: https://www.aefi2023.com/

Continue ReadingJosé Alberto Ayala Ortiz to participate in the AEFI Symposium 2023

Is the Local Medical Literature Search in Pharmacovigilance really an obligation?

  • Post published:January 19, 2022

It is well known that the medical literature is a significant source of information for the monitoring of the safety profile and of the risk-benefit balance of medicinal products. However, we may have doubts about whether it is really mandatory or not. And indeed, yes, it is an obligation. The European Medicines Agency confirms this in the Good Pharmacovigilance Practices (GVP) Module VI: "The marketing authorisation holder should ensure that the literature review includes the use of reference databases that contain the largest reference of articles in relation to the medicinal product properties." "In addition, marketing authorisation holders should have procedures…

Continue ReadingIs the Local Medical Literature Search in Pharmacovigilance really an obligation?